|
|
The effect of Major Capillaries Decoction and Bubleurum Decoction on liver ischemia reperfusion injury in rats |
ZHANG Beiping1 ZHAI Shuping2 YUAN Wei2 YAN Yong2 ZHANG Xiaobing1 WANG Bailin2▲ |
1.Guizhou Medical University, Guizhou Province, Guiyang 550004, China;
2.Department of General Surgery, Guangzhou Red Cross Hospital, Ji′nan University Faculty of Medical Science, Guangdong Province, Guangzhou 510220, China |
|
|
Abstract Objective To observe the protective effect of Major Capillaries Decoction and Bubleurum Decoction on liver ischemia-reperfusion injury in rats. Methods Liver ischemia-reperfusion model rats were randomly divided into ischemia-reperfusion Chinese medicine group (TCM group, n = 75), ischemia-reperfusion control group (control group, n = 75), and sham operation group (sham group, n = 75). The contents of interleukin-1 (IL-1) in serum, intercellular adhesion molecule-1 (ICAM-1) and nuclear factor-kappa B (NF-κB) in rat liver homogenate tissue were measured by enzyme-linked immunosorbent assay (ELISA) and Western blot. Results After ischemia and reperfusion in three groups, serum IL-1 content gradually increased with the extension of time. In the same time after ischemia-reperfusion, the serum IL-1 content of TCM group was significantly lower than that of the control group, the differences were highly statistically significant (P < 0.01). The expression of NF-κB and ICAM-1 in the liver homogenate tissue of TCM group and control group increased gradually with the extension of time, and the expression of TCM group was higher than that of control group at the same time point(P < 0.05). Conclusion Major Capillaries Decoction and Bubleurum Decoction can significantly alleviate liver ischemia-reperfusion injury in rats. It may be through inhibiting the activation of NF-κB and reducing the expression of ICAM-1 and IL-1 to play a protective role in ischemia-reperfusion injury.
|
|
|
|
|
[1] Meng GX,Yuan Q,Wei LP,et al. Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats [J]. Exp Ther Med,2016,11(2):565-570.
[2] Teoh NC,Ajamieh H,Wong HJ,et al. Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)[J]. PLoS One,2014,9(9):e104376.
[3] Zhai Y,Petrowsky H,Hong JC,et al. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside [J]. Nat Rev Gastroenterol Hepatol,2013,10(2):79-89.
[4] Su P,Liu X,Pang Y,et al. The archaic roles of the lamprey NF-κB(lj-NF-κB)in innate immune responses [J]. Mol Immunol,2017,92:21-27.
[5] Duval F,Moreno-Cuevas JE,González-Garza MT,et al. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response [J]. Int J Inflam,2015,2015:943497.
[6] Dabrowski A,Osada J,Dabrowska MI,et al. Increased expression of the intercellular adhesion molecule-1(ICAM-1)on peripheral blood neutrophils in acute pancreatitis [J]. Adv Med Sci,2014,59(1):102-107.
[7] 苑伟.通腑泄热法对梗阻性黄疸肝细胞mtDNA氧化损伤的保护作用研究[D].广州:广州中医药大学,2014.
[8] 王百林,苑伟,翟淑萍,等.梗阻性黄疸兔肝细胞线粒体氧化损伤的作用及机制[J].中华实验外科杂志,2014,31(11):2393-2395.
[9] 王百林,苑伟,翟淑萍,等.利胆消黄汤对梗阻性黄疸兔肝细胞线粒体DNA损伤修复的研究[J].中华实验外科杂志,2015,32(11):2636-2638.
[10] 余淑珍,郭永清,郑李娜,等.SD大鼠急性全肝缺血再灌注模型建立与改良[J].中国药物与临床,2016,16(1):28-30.
[11] Zhai Y,Busuttil RW,Kupiec-Weglinski JW. Liver ischemia and reperfusion injury:new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation [J]. Am J Transplant,2011,11(8):1563-1569.
[12] Su S,Luo,Liu X,et al. miR-494 up-regulates the PI3K/Akt pathway via targetting PTEN and attenuates hepatic ischemia/reperfusion injury in a rat model [J]. Biosci Rep,2017,37(5):BSR20170798.
[13] Lin TH,Pajarinen J,Lu L,et al. NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases [J]. Adv Protein Chem Struct Biol,2017,107:117-154.
[14] Anbarasan C,Bavanilatha M,Latchumanadhas K,et al. ICAM-1 molecular mechanism and genome wide SNP's association studies [J]. Indian Heart J,2015,67(3):282-287.
[15] Jing SH,Xuan G,Bo Y,et al. Raf Kinase Inhibitor Protein(RKIP)Inhibits Tumor Necrosis Factor-α(TNF-α)Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing(Nuclear Transcription Factor-κB(NF-kappaB)Pathway [J]. Med Sci Monit,2017,23:4789-4797.
[16] He D,Guo Z,Pu JL,et al. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro,and in vivo [J]. Int Immunopharmacol,2016,35:201-209.
[17] 华圆,冯健,李范珠.茵陈蒿汤利胆退黄物质基础的研究进展[J].中华中医药学刊,2011,29(7):1520-1521.
[18] 费国新.加味大柴胡汤辅助治疗原发性肝癌合并阻塞性黄疸的临床观察[J].湖北中医杂志,2010,32(9):36-37.
[19] 林木生,王三明,包仕廷,等.加味大柴胡汤加用L-精氨酸对阻黄大鼠血浆内毒素的影响[J].中华实验外科杂志,2004,21(10):1202-1203.
[20] Robertson FP,Fuller BJ,Davidson BR. An Evaluation of Ischaemic Preconditioning as a Method of Reducing Ischaemia Reperfusion Injury in Liver Surgery and Transplantation [J]. J Clin Med,2017,6(7):E69.
[21] Yu Q,Zeng KW,Ma XL,et al. Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells by inhibiting the Jak2/Stat3 pathway [J]. Chin J Nat Med,2017,15(10):751-757. |
|
|
|